Minister for Health Simon Harris said: “Clinical trials are at the heart of improved prevention, diagnosis and treatment of diseases. For over a decade now the Department of Health, working closely with the Health Research Board, has invested in infrastructure and capacity to support clinical trials in Ireland. While some trials can be conducted on a national level, many trials require access to large populations of patients and collaborations across centres and countries. This will be facilitated by Ireland becoming a member of ECRIN.
“Today’s decision represents an important development for current and future patients in Ireland. It is a positive development for the health research community and it enhances Ireland’s reputation as a place to conduct industry trials. This will drive change and improve patient outcomes but also advance innovation, productivity and competitiveness.”
<br />Ireland is likely to hold a unique place in the European clinical trial arena as the only “mature” English-speaking country in Europe post-Brexit, according to a Department of Health statement.
“As a member of ECRIN, Ireland would be perfectly positioned to take on the country sponsor role for more pan-European clinical trials,” according to the statement.